{"id":"placebo-for-comparator","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3983509","moleculeType":"Small molecule","molecularWeight":"434.92"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not contain any active pharmaceutical ingredient and therefore does not have a known mechanism of action.","oneSentence":"This drug has no known mechanism of action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:04.378Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07433556","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers","status":"RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2026-03-23","conditions":"Healhty","enrollment":86},{"nctId":"NCT06456346","phase":"PHASE3","title":"Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-16","conditions":"Essential Thrombocythemia","enrollment":300},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT05142735","phase":"NA","title":"Effects of NAC on Symptoms of CHR Patients","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-01-13","conditions":"Prodromal Schizophrenia","enrollment":90},{"nctId":"NCT05630781","phase":"NA","title":"Orexin s Role in the Neurobiology of Substance Use Disorder","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-15","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT07496944","phase":"NA","title":"Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2026-01-20","conditions":"Athletic Performance","enrollment":40},{"nctId":"NCT07046494","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder","status":"RECRUITING","sponsor":"Rapport Therapeutics Inc.","startDate":"2025-07-25","conditions":"Bipolar 1 Disorder","enrollment":224},{"nctId":"NCT07210515","phase":"PHASE3","title":"Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)","status":"RECRUITING","sponsor":"Ambros Therapeutics, Inc.","startDate":"2026-03","conditions":"Complex Regional Pain Syndrome Type I","enrollment":270},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT06742723","phase":"PHASE3","title":"A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-03","conditions":"Chronic Kidney Disease and Hypertension","enrollment":5000},{"nctId":"NCT04660344","phase":"PHASE3","title":"A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-05-03","conditions":"Muscle-invasive Bladder Cancer","enrollment":761},{"nctId":"NCT07266402","phase":"PHASE3","title":"A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)","status":"RECRUITING","sponsor":"Celldex Therapeutics","startDate":"2026-01-15","conditions":"Chronic Inducible Urticaria, Cold Urticaria, Cold-Induced Urticaria","enrollment":240},{"nctId":"NCT06123754","phase":"PHASE3","title":"Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC","status":"RECRUITING","sponsor":"3D Medicines (Sichuan) Co., Ltd.","startDate":"2023-11-17","conditions":"Non-small Cell Lung Cancer","enrollment":390},{"nctId":"NCT06439875","phase":"NA","title":"Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2024-07-16","conditions":"Chronic Obstructive Pulmonary Disease, Respiratory Failure","enrollment":101},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT04745143","phase":"PHASE2","title":"Monotherapy of an NMDA Enhancer for Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2018-01-01","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT07491458","phase":"PHASE2","title":"A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Rivus Pharmaceuticals, Inc.","startDate":"2026-02-13","conditions":"MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":180},{"nctId":"NCT05052853","phase":"PHASE2","title":"Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2021-11-01","conditions":"Prodromal Schizophrenia","enrollment":48},{"nctId":"NCT06077760","phase":"PHASE3","title":"A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-06","conditions":"Non-small Cell Lung Cancer","enrollment":868},{"nctId":"NCT06574360","phase":"PHASE2","title":"Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2024-09-23","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT07362446","phase":"PHASE2","title":"Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Nyrada Pty Ltd","startDate":"2026-04-16","conditions":"Myocardial Infarction, Reperfusion Injury, AMI","enrollment":300},{"nctId":"NCT07300514","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Maintenance Treatment of Peripheral T-cell Lymphoma","enrollment":136},{"nctId":"NCT05120830","phase":"PHASE1, PHASE2","title":"NTLA-2002 in Adults With Hereditary Angioedema (HAE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2021-12-10","conditions":"Hereditary Angioedema","enrollment":37},{"nctId":"NCT05240976","phase":"PHASE2","title":"Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2022-02-23","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT06319118","phase":"PHASE4","title":"A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2023-10-01","conditions":"Salivation in Parkinson's Disease","enrollment":120},{"nctId":"NCT06641466","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-03-11","conditions":"Menstrual Migraine","enrollment":723},{"nctId":"NCT07245368","phase":"PHASE1, PHASE2","title":"Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma","status":"RECRUITING","sponsor":"Prana Therapies Inc","startDate":"2025-11-04","conditions":"Mild to Moderate Asthma","enrollment":96},{"nctId":"NCT04627922","phase":"PHASE4","title":"N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use","status":"COMPLETED","sponsor":"Ellen Herbst","startDate":"2021-08-25","conditions":"Cannabis Use, Tobacco Use Disorder, Drug Use Disorder","enrollment":59},{"nctId":"NCT06467539","phase":"PHASE2","title":"Novel Augmentation of DAOIB and Antioxidant for Early Dementia","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-06-19","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":80},{"nctId":"NCT06282588","phase":"PHASE2, PHASE3","title":"Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2023-12-13","conditions":"Prostate Cancer","enrollment":493},{"nctId":"NCT07481734","phase":"PHASE2","title":"Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis","enrollment":120},{"nctId":"NCT05480228","phase":"PHASE2","title":"EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA","status":"COMPLETED","sponsor":"James P. Rathmell, MD","startDate":"2022-09-21","conditions":"Painful Diabetic Neuropathy","enrollment":127},{"nctId":"NCT07267559","phase":"PHASE4","title":"Dual Orexin Antagonism and Emotion and Affective Processing Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Learning, Cognitive Functioning, Emotional Processing","enrollment":62},{"nctId":"NCT05476276","phase":"PHASE2","title":"EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"James P. Rathmell, MD","startDate":"2022-09-21","conditions":"Painful Diabetic Neuropathy","enrollment":127},{"nctId":"NCT07483398","phase":"PHASE4","title":"RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-13","conditions":"Parkinson's Disease With Nociceptive Pain","enrollment":166},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07382167","phase":"PHASE3","title":"A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults","status":"RECRUITING","sponsor":"Ardelyx","startDate":"2026-01-13","conditions":"Chronic Idiopathic Constipation (CIC)","enrollment":692},{"nctId":"NCT07446517","phase":"NA","title":"Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-03-01","conditions":"Osgood-Schlatter Disease, Sever's Disease","enrollment":30},{"nctId":"NCT06113328","phase":"PHASE2","title":"A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-27","conditions":"Non-segmental Vitiligo","enrollment":169},{"nctId":"NCT04404283","phase":"PHASE3","title":"Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seagen, a wholly owned subsidiary of Pfizer","startDate":"2020-08-20","conditions":"Diffuse Large B-cell Lymphoma","enrollment":238},{"nctId":"NCT05618353","phase":"PHASE4","title":"The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-08-21","conditions":"Coronary Artery Disease","enrollment":700},{"nctId":"NCT07474636","phase":"PHASE2","title":"Efficacy and Safety Study of HS-10542 for IgA Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","startDate":"2026-03-17","conditions":"IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease","enrollment":90},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":"Chronic Low Back Pain","enrollment":108},{"nctId":"NCT07474077","phase":"PHASE3","title":"Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-05-01","conditions":"Post Partum Haemorrhage","enrollment":88},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT06878404","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-21","conditions":"Arthritis, Psoriatic","enrollment":552},{"nctId":"NCT07467473","phase":"NA","title":"Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression","status":"ENROLLING_BY_INVITATION","sponsor":"Florida State University","startDate":"2026-03-23","conditions":"Left Rostromedial Prefrontal Cortex - Accelerated Intermittent Theta Burst, Left Dorsolateral Prefrontal Cortex - Accelerated Intermittent Theta Burst, Left Primary Somatosensory Cortex - Accelerated Intermittent Theta Burst","enrollment":48},{"nctId":"NCT06645847","phase":"NA","title":"Targeting Aging With a Ketone Ester for Function in Frailty","status":"RECRUITING","sponsor":"Buck Institute for Research on Aging","startDate":"2025-02-05","conditions":"Frail Elderly, Aging, Immune Function","enrollment":180},{"nctId":"NCT06934226","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-04-15","conditions":"Plaque Psoriasis","enrollment":752},{"nctId":"NCT07469878","phase":"NA","title":"Mobile Shared Decision-Making Program for ICU Caregivers","status":"COMPLETED","sponsor":"CHIA-HUI MA","startDate":"2021-08-28","conditions":"Terminally Ill Patients","enrollment":70},{"nctId":"NCT07273838","phase":"PHASE2","title":"Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-03-05","conditions":"Heart Failure, Acute Kidney Injury","enrollment":130},{"nctId":"NCT06719141","phase":"PHASE3","title":"A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)","status":"RECRUITING","sponsor":"Longboard Pharmaceuticals","startDate":"2024-11-11","conditions":"Developmental and Epileptic Encephalopathy","enrollment":320},{"nctId":"NCT06608277","phase":"PHASE2","title":"Ketamine, SGB and Combination Treatment for TBI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-02","conditions":"Posttraumatic Headache, Posttraumatic Stress Disorder","enrollment":175},{"nctId":"NCT06660394","phase":"PHASE3","title":"A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)","status":"RECRUITING","sponsor":"Longboard Pharmaceuticals","startDate":"2024-09-25","conditions":"Dravet Syndrome","enrollment":160},{"nctId":"NCT03451851","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-07-11","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT07112872","phase":"PHASE2","title":"A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-08-19","conditions":"Type 2 Diabetes Mellitus","enrollment":240},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT06143878","phase":"PHASE3","title":"A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-01","conditions":"Plaque Psoriasis","enrollment":774},{"nctId":"NCT06220604","phase":"PHASE3","title":"A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-03-09","conditions":"Plaque Psoriasis","enrollment":731},{"nctId":"NCT07452744","phase":"NA","title":"Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Bioagile Therapeutics Pvt. Ltd.","startDate":"2024-08-13","conditions":"Non Alcholic Fatty Liver Disease","enrollment":170},{"nctId":"NCT07464886","phase":"PHASE3","title":"Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2026-02-26","conditions":"Mild Depression","enrollment":160},{"nctId":"NCT06132581","phase":"NA","title":"Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression","status":"RECRUITING","sponsor":"Florida State University","startDate":"2024-01-24","conditions":"Major Depressive Disorder, Anhedonia","enrollment":72},{"nctId":"NCT06042478","phase":"PHASE3","title":"Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-11-15","conditions":"Chronic Spontaneous Urticaria","enrollment":470},{"nctId":"NCT07214974","phase":"EARLY_PHASE1","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","status":"NOT_YET_RECRUITING","sponsor":"Noah Tech, Corp.","startDate":"2026-09-01","conditions":"Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline, Alzheimer's Disease Dementia","enrollment":600},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT07167966","phase":"PHASE2","title":"Alzheimer's Tau Platform: Regimen A - AADvac1","status":"NOT_YET_RECRUITING","sponsor":"Paul S. Aisen","startDate":"2026-06-30","conditions":"Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease, Alzheimer Disease","enrollment":375},{"nctId":"NCT07453212","phase":"NA","title":"Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction","status":"ENROLLING_BY_INVITATION","sponsor":"Varol TUNALI","startDate":"2026-03-01","conditions":"Dry Eye, Evaporative Dry Eye Disease, Meibomian Gland Dysfunction (Disorder)","enrollment":130},{"nctId":"NCT06671483","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-03","conditions":"Psoriatic Arthritis","enrollment":1088},{"nctId":"NCT06973109","phase":"PHASE2","title":"Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nitin Agarwal","startDate":"2026-03-20","conditions":"Osteoporosis, Post-menopausal","enrollment":36},{"nctId":"NCT06961006","phase":"PHASE2","title":"A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-29","conditions":"Malignant Melanoma","enrollment":160},{"nctId":"NCT03822637","phase":"PHASE4","title":"The Effect of NAC on Lung Function and CT Mucus Score","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-02-20","conditions":"Asthma","enrollment":4},{"nctId":"NCT07444996","phase":"NA","title":"Effect of Magnetotherapy Combined With Cold Application and Exercise in Patients With Lateral Epicondylitis","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-27","conditions":"Magnetotherapy, Lateral Epicondylitis (Tennis Elbow)","enrollment":40},{"nctId":"NCT07456449","phase":"NA","title":"Collagen Peptides and Cellular Aging","status":"NOT_YET_RECRUITING","sponsor":"University of Vienna","startDate":"2026-02","conditions":"Longevity, Healthy Aging, Biological Ageing","enrollment":125},{"nctId":"NCT06166056","phase":"PHASE1, PHASE2","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-11-29","conditions":"Bronchiectasis","enrollment":45},{"nctId":"NCT07452562","phase":"NA","title":"Hesperidin RCT in MS","status":"RECRUITING","sponsor":"Swansea University","startDate":"2026-01-07","conditions":"Multiple Sclerosis","enrollment":60},{"nctId":"NCT06582706","phase":"PHASE1, PHASE2","title":"Nicotinic Acid for the Treatment of Alzheimer's Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2024-12-19","conditions":"Alzheimer Disease","enrollment":30},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT06937931","phase":"PHASE2","title":"A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults","status":"RECRUITING","sponsor":"Ipsen","startDate":"2025-06-30","conditions":"Cervical Dystonia","enrollment":132},{"nctId":"NCT07447349","phase":"NA","title":"Effect of Nigella Sativa Toothpaste on Salivary Biomarkers in Patients With Gingivitis","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2023-01-01","conditions":"Gingivitis","enrollment":100},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT05696080","phase":"PHASE3","title":"Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-13","conditions":"Pneumococcal Infection","enrollment":518},{"nctId":"NCT07305818","phase":"PHASE1","title":"NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease","status":"RECRUITING","sponsor":"Merida Biosciences","startDate":"2025-12-19","conditions":"Graves Disease","enrollment":100},{"nctId":"NCT06934252","phase":"PHASE1","title":"Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients","status":"RECRUITING","sponsor":"TRex Bio, Inc.","startDate":"2025-05-02","conditions":"Moderate-to-severe Atopic Dermatitis","enrollment":115},{"nctId":"NCT05754073","phase":"PHASE2","title":"Oxytocin Effects on Bone in Children With Autism Spectrum Disorder","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2023-08-01","conditions":"Autism Spectrum Disorder, Bone Health","enrollment":96},{"nctId":"NCT07441421","phase":"NA","title":"Perioperative Multimodal Analgesia for Supratentorial Craniotomy","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-01","conditions":"Postoperative Pain, Analgesia, Supratentorial Brain Tumor","enrollment":2000},{"nctId":"NCT05428033","phase":"PHASE3","title":"A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-07-11","conditions":"Attention Deficit/Hyperactivity Disorder","enrollment":574},{"nctId":"NCT04115033","phase":"NA","title":"Randomized Controlled Trial of CES for Fibromyalgia","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-03-02","conditions":"Fibromyalgia","enrollment":50},{"nctId":"NCT07437586","phase":"PHASE2","title":"Topical GHK-Cu Gel for Acute Skin Wound Healing","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)","enrollment":60},{"nctId":"NCT07439510","phase":"PHASE2, PHASE3","title":"A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants","status":"NOT_YET_RECRUITING","sponsor":"Spinogenix","startDate":"2026-03-01","conditions":"Fragile X Syndrome (FXS)","enrollment":248},{"nctId":"NCT07090161","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension","status":"RECRUITING","sponsor":"Vanda Pharmaceuticals","startDate":"2025-09-15","conditions":"Hypertension, Uncontrolled Hypertension","enrollment":240},{"nctId":"NCT07439042","phase":"PHASE4","title":"Buspirone for Anxiety in Autistic Youth","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-08","conditions":"Anxiety, Autism Spectrum Disorder","enrollment":20},{"nctId":"NCT07437547","phase":"PHASE2","title":"BPC 157 for Acute Hamstring Muscle Strain Repair","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Hamstring Muscle Strain, Skeletal Muscle Injury","enrollment":120},{"nctId":"NCT07432893","phase":"NA","title":"Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts","status":"RECRUITING","sponsor":"Sarah Nabia","startDate":"2026-01-13","conditions":"Hypertension, Diabete Mellitus, Breathlessness","enrollment":672},{"nctId":"NCT07266805","phase":"PHASE3","title":"Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency","status":"RECRUITING","sponsor":"Pharvaris Netherlands B.V.","startDate":"2025-10-16","conditions":"Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)","enrollment":32},{"nctId":"NCT07198607","phase":"NA","title":"Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2024-03-04","conditions":"Chronic Rhinosinusitis Without Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)","enrollment":100},{"nctId":"NCT07076498","phase":"PHASE1","title":"Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-12-01","conditions":"Glioma","enrollment":20},{"nctId":"NCT07431476","phase":"PHASE4","title":"Brimonidine 0.33% for Rosacea-Related Facial Erythema","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2025-05-01","conditions":"Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)","enrollment":45},{"nctId":"NCT05799755","phase":"PHASE4","title":"Myositis Interstitial Lung Disease Nintedanib Trial","status":"COMPLETED","sponsor":"Rohit Aggarwal, MD","startDate":"2023-08-01","conditions":"Myositis Associated Interstitial Lund Disease (MA-ILD)","enrollment":49}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2637,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sugar pill"],"phase":"phase_3","status":"active","brandName":"Placebo for comparator","genericName":"Placebo for comparator","companyName":"Akros Pharma Inc.","companyId":"akros-pharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}